Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 11Carcinoma, Ovarian Epithelial 4Small Cell Lung Carcinoma 2Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Platinum-resistant Ovarian Cancer 1Pancreatic Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Nausea 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Kenny-Caffey syndrome, Type 1 1Gonadal Disorders 1Glioblastoma 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endometrial Neoplasms 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1

Interventions

Dexamethasone 6Aprepitant 5Olanzapine 4Palonosetron 3Granisetron 2yangzheng xiaoji 1stinging nettle lectin 1ramosetron 1peppermint oil 1niraparib 1netupitant, palosentron drug combination 1netupitant 1lerisetron 1fosaprepitant 1Whole Body Imaging 1Tropisetron 1Transcranial Direct Current Stimulation 1Tablets 1Radiotherapy 1Paclitaxel 1Ondansetron 1Music Therapy 1Metoclopramide 1Carboplatin 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Nausea × niraparib × Clear all
NCT05641506 2022-12-07

A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown
50 enrolled
Gynecologic

Nausea, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡